BeStock  
Stocks › Biotechnology › IMTX

Immatics IMTX

US equityMarket cap rank #3243Biotechnology
$5.77 −$0.18 (-3.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.88 +1.91%
Open$5.86
Prev close$5.95
Day range$5.72 – $5.95
Volume746.7K
Market cap$878.58M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€6.92M+33.5% YoY
Operating profit-€78.54M-43.8% YoY
Net profit-€76.02M-50.4% YoY
Diluted EPS-€0.50-19.0% YoY
Free cash flow-€61.50M-34.3% YoY
Operating cash flow-€60.70M

Revenue, last 8 quarters

€56.3MDec '24€18.6MMar '25€4.7MJun '25€5.2MSep '25€19.8MDec '25€7.6MMar '26€9.1MJun '26€6.9MSep '26

Net profit, last 8 quarters

€40.8MDec '24€-39.9MMar '25€-70.3MJun '25€-50.5MSep '25€-35.7MDec '25€-57.8MMar '26€-62.5MJun '26€-76.0MSep '26

Diluted EPS by quarter

0.39Dec '24-0.33Mar '25-0.58Jun '25-0.42Sep '25-0.29Dec '25-0.43Mar '26-0.46Jun '26-0.50Sep '26

Free cash flow by quarter

€-60.2MDec '24€-37.3MMar '25€-40.6MJun '25€-45.8MSep '25€-59.7MDec '25€-42.8MMar '26€-61.3MJun '26€-61.5MSep '26

Annual revenue

€31.3MFY20€34.8MFY21€172.8MFY22€54.0MFY23€155.8MFY24€48.3MFY25

Profitability & balance sheet

Operating margin-577.1%
Net margin-526.6%
Return on equity-53.5%
Return on assets-42.2%
Return on invested capital-54.6%
Current ratio5.03
Liabilities / assets22.5%
Cash & investments€472.27M
Total debt€11.45M
Net cash (debt)€460.82M

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Revenue as Reported €6.92M €9.14M €7.61M €48.27M €19.76M
Total Operating Revenue €6.92M €9.14M €7.61M €48.27M €19.76M
Operating Expense €85.47M €76.35M €73.68M €230.28M €58.64M
Selling and Admin Expenses €15.81M €13.94M €14.51M €51.18M €13.66M
-General & Admin Expense €15.81M €13.94M €14.51M €51.18M €13.66M
Research & Development €70.27M €62.41M €59.19M €183.83M €49.64M
Other Operating Expenses -€615,000.00 – -€24,000.00 -€4.73M -€4.66M
Operating Profit -€78.54M -€67.20M -€66.06M -€182.02M -€38.88M
Net Non-Operating Interest Income (Expense) €3.14M €3.08M €3.37M €16.23M €3.33M
Non-Operating Interest Income €3.34M €3.29M €3.58M €17.18M €3.55M
Non-Operating Interest Expense €200,000.00 €203,000.00 €212,000.00 €946,000.00 €222,000.00
Other Income (Expense) -€1.03M €1.35M €4.93M -€32.65M -€11,000.00
Gain on Sale of Security -€1.03M €1.35M €4.93M -€32.65M -€11,000.00
Pretax Profit -€76.43M -€62.77M -€57.76M -€198.44M -€35.56M
Tax -€407,000.00 -€274,000.00 €52,000.00 -€1.99M €134,000.00
Net Profit -€76.02M -€62.49M -€57.81M -€196.45M -€35.70M
Profit from Continuing Operations -€76.02M -€62.49M -€57.81M -€196.45M -€35.70M
Net Income to Parent Company -€76.02M -€62.49M -€57.81M -€196.45M -€35.70M
Other Preferred Stock Dividends -€3.26M €0.00 – – –
Net Income to Common Stockholders -€72.76M -€62.49M -€57.81M -€196.45M -€35.70M
Basic EPS -€0.50 -€0.46 -€0.43 -€1.61 -€0.29
Diluted EPS -€0.50 -€0.46 -€0.43 -€1.61 -€0.29

Balance sheet

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Assets €565.72M €485.74M €543.26M €562.34M €562.34M
Total Current Assets €510.94M €429.19M €484.84M €504.01M €504.01M
Cash and Cash Equivalents & Short-Term Investments €472.27M €393.35M €453.57M €469.34M €469.34M
-Cash and Cash Equivalents €276.61M €232.46M €301.33M €345.92M €345.92M
-Short Term Investments €195.66M €160.89M €152.24M €123.42M €123.42M
Receivables €22.64M €6.66M €4.82M €6.88M €6.88M
-Accounts Receivable €7.40M €5.63M €4.15M €6.10M €6.10M
-Taxes Receivable €8.69M €1.04M €662,000.00 €782,000.00 €782,000.00
-Other Receivables €6.55M – – – –
Prepaid Assets €13.83M €10.59M €8.86M €12.92M €12.92M
Other Current Assets €2.20M €18.59M €17.59M €14.87M €14.87M
Total Non-Current Assets €54.78M €56.54M €58.43M €58.33M €58.33M
Net PPE €49.67M €51.70M €53.44M €54.90M €54.90M
-Gross PPE €49.67M €51.70M €53.44M €84.66M €84.66M
Non-Current Prepaid Assets €2.75M €2.58M €2.71M €1.08M €1.08M
Goodwill and Other Intangible Assets €1.66M €1.56M €1.58M €1.58M €1.58M
Other Non-Current Assets €700,000.00 €700,000.00 €698,000.00 €769,000.00 €769,000.00
Total Liabilities €127.22M €86.11M €87.46M €78.24M €78.24M
Total Current Liabilities €101.67M €56.95M €55.25M €43.01M €43.01M
Payables €10.12M €7.11M €8.85M €2.69M €2.69M
-Accounts Payable €9.19M €6.24M €8.05M €340,000.00 €340,000.00
-Total Tax Payable €930,000.00 €865,000.00 €797,000.00 €2.35M €2.35M
Current Accrued Expenses €31.09M €26.91M €23.53M €18.49M €18.49M
Short-Term Debt and Capital Lease Obligation €2.50M €2.67M €2.61M €2.76M €2.76M
-Current Capital Lease Obligation €2.50M €2.67M €2.61M €2.76M €2.76M
Current Deferred Liabilities €11.11M €9.57M €13.22M €15.82M €15.82M
Other Current Liabilities €35.96M €1.99M €2.35M €1.55M €1.55M
Total Non-Current Liabilities €25.55M €29.16M €32.21M €35.23M €35.23M
Long Term Debt and Capital Lease Obligation €11.45M €11.94M €12.47M €12.88M €12.88M
-Long Term Capital Lease Obligation €11.45M €11.94M €12.47M €12.88M €12.88M
Non-Current Deferred Liabilities €14.10M €17.22M €19.74M €22.35M €22.35M
Total Equity €438.50M €399.63M €455.80M €484.10M €484.10M
Stockholders' Equity €438.50M €399.63M €455.80M €484.10M €484.10M
Capital Stock €1.52M €1.37M €1.37M €1.34M €1.34M
-Common Stock €1.52M €1.37M €1.37M €1.34M €1.34M
Additional Paid-In Capital €1.42B €1.31B €1.30B €1.28B €1.28B
Retained Earnings -€982.32M -€906.29M -€843.80M -€785.99M -€785.99M
Gains/Losses Not Affecting Retained Earnings -€5.17M -€5.53M -€6.72M -€8.59M -€8.59M
-Accumulated Depreciation – – – -€29.76M -€29.76M
-Other Intangible Assets – – – €1.58M €1.58M

Cash flow

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Operating Cash Flow -€60.70M -€60.46M -€42.04M -€176.63M -€58.67M
Net cash flow from continuing operations -€60.70M -€60.46M -€42.04M -€176.63M -€58.67M
Net Income from Continuing Operations -€76.65M -€62.49M -€57.81M -€196.45M -€33.58M
Gain/Loss from Continuing Operations €1.26M -€1.36M -€5.42M €33.15M €814,000.00
Depreciation & Depletion & Amortization €2.88M €3.00M €2.78M €12.40M €3.17M
Other Non-Cash Items -€3.14M -€3.08M -€3.37M -€16.23M -€3.33M
Change in Working Capital €4.05M -€4.28M €13.50M -€43.97M -€30.04M
-Change in Receivables -€1.77M -€1.34M €1.95M -€242,000.00 -€2.90M
-Change in Other Current Assets -€3.03M -€2.42M €1.16M -€6.11M -€4.55M
-Change In Other Working Capital €8.86M -€524,000.00 €10.40M -€37.62M -€22.59M
Net cash flow from investing -€34.67M -€8.15M -€28.08M €204.79M -€28.92M
Net Cash Flow from Continuing Investing Activities -€34.67M -€8.15M -€28.08M €204.79M -€28.92M
Net PPE Purchase and Sale -€665,000.00 -€868,000.00 -€739,000.00 -€6.56M -€1.02M
Net Intangibles Purchase and Sale -€129,000.00 €0.00 €0.00 -€247,000.00 -€57,000.00
Net Investment Purchase and Sale -€33.87M -€7.29M -€27.35M €211.59M -€27.85M
Financing Cash Flow €137.89M -€666,000.00 €20.97M €97.35M €99.55M
Net Cash Flow from Continuing Financing Activities €137.89M -€666,000.00 €20.97M €97.35M €99.55M
Net Issuance Payments Of Debt -€784,000.00 -€723,000.00 -€760,000.00 -€2.96M -€748,000.00
Net Common Stock Issuance €148.03M €57,000.00 €22.27M €107.31M €107.30M
Net Other Financing Charges -€9.35M €0.00 -€542,000.00 -€7.00M –
Ending Cash Balance €276.61M €232.46M €301.33M €345.92M €345.92M
Net Change in Cash €42.53M -€69.28M -€49.16M €125.51M €11.97M
Beginning Cash Balance €232.46M €301.33M €345.92M €236.75M €334.92M
Effect of Exchange Rate Changes €1.63M €407,000.00 €4.57M -€16.34M -€970,000.00
Free Cash Flow -€61.50M -€61.33M -€42.81M -€183.43M -€59.69M
Deferred Tax – -€274,000.00 €52,000.00 -€1.99M –

Discussion

No comments yet — be the first to weigh in on IMTX.

Sign in to join the discussion.

Scroll to Top